Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade

Abstract Immune checkpoint inhibitors have demonstrated broad single-agent antitumor activity and a favorable safety profile that render them attractive agents to combine with other systemic anticancer therapies. Pancreatic cancer has been fairly resistant to monotherapy blockade of programmed cell...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Jun Gong, Andrew Hendifar, Richard Tuli, Jeremy Chuang, May Cho, Vincent Chung, Daneng Li, Ravi Salgia
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2018-10-01
Reeks:	Clinical and Translational Medicine
Onderwerpen:	Pancreatic cancer Checkpoint inhibitor Combination therapy Immuno-oncology Clinical trials
Online toegang:	http://link.springer.com/article/10.1186/s40169-018-0210-9
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!